BRIP1 Gene Mutation: Clinical Trials

1 trial for BRIP1 Gene Mutation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow BRIP1 Gene Mutation: new trials by email Literature Review of BRIP1 Gene Mutation trials Research Report on BRIP1 Gene Mutation

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response Defects
Niraparib, Niraparib Tosylate Monohydrate, Radical Prostatectomy - ATM Gene Mutation, BRCA1 Gene Mutation
Phase 2TerminatedUniversity of California, Davis112020-02-252026-05-14

Narrower conditions

Prostatic Neoplasms (1)

Broader conditions

Genital Diseases (1)  ·  Genital Diseases, Male (1)  ·  Genital Neoplasms, Male (1)  ·  Male Urogenital Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Prostatic Diseases (1)  ·  Urogenital Diseases (1)  ·  Urogenital Neoplasms (1)

Interventions

niraparib (1)

Sponsors

University of California, Davis (1)

Countries

United States (1)

Top investigators

Marc Dall'Era (1)

Results publications

PMID 36710203

NIH funding

P30CA093373 (1)